Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

Evaluation of Pre-Existing Levels of Y448H HCV NS5B Polymerase Mutant Using Viral Kinetics Monitored by Allele-Specific PCR in HCV Patients and Replicon Cells Treated with the HCV Non-Nucleoside Inhibitor Tegobuvir       Reported by Jules Levin AASLD Nov 5-8 2011 SF   KS Ku, D Goodman, P Pang, MD Miller, H Mo, ES Svarovskaia Gilead Sciences, Foster City, CA United States